Search Results - "Hoewner, A."

Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma by Shannan, B., Matschke, J., Chauvistré, H., Vogel, F., Klein, D., Meier, F., Westphal, D., Bruns, J., Rauschenberg, R., Utikal, J., Forschner, A., Berking, C., Terheyden, P., Dabrowski, E., Gutzmer, R., Rafei-Shamsabadi, D., Meiss, F., Heinzerling, L., Zimmer, L., Livingstone, Elisabeth, Váraljai, Renáta, Hoewner, A., Horn, S., Klode, J., Stuschke, M., Scheffler, B., Marchetto, A., Sannino, G., Grünewald, T.G.P., Schadendorf, D., Jendrossek, V., Roesch, A.

“…Treatment of patients with metastatic melanoma is hampered by drug-resistance and often requires combination with radiotherapy as last-resort option. However,…”
Get full text

Sequence-dependent cross-resistance of combined radiotherapy plus BRAF V600E inhibition in melanoma by Shannan, B, Matschke, J, Chauvistré, H, Vogel, F, Klein, D, Meier, F, Westphal, D, Bruns, J, Rauschenberg, R, Utikal, J, Forschner, A, Berking, C, Terheyden, P, Dabrowski, E, Gutzmer, R, Rafei-Shamsabadi, D, Meiss, F, Heinzerling, L, Zimmer, L, Livingstone, Elisabeth, Váraljai, Renáta, Hoewner, A, Horn, S, Klode, J, Stuschke, M, Scheffler, B, Marchetto, A, Sannino, G, Grünewald, T G P, Schadendorf, D, Jendrossek, V, Roesch, A

“…Treatment of patients with metastatic melanoma is hampered by drug-resistance and often requires combination with radiotherapy as last-resort option. However,…”
Get full text